Efficient Utilization of Korean Medical Fungal Pathogen Resource Bank for Clinical Research

Q4 Medicine

Journal of Mycology and Infection Pub Date : 2019-09-30 DOI:10.17966/jmi.2019.24.3.69

Jayoung Kim, Junsang Oh, G. Sung, Hyeyoung Lee, J. Choi, Sangheun Lee, Minbum Kim, S. Choi

{"title":"Efficient Utilization of Korean Medical Fungal Pathogen Resource Bank for Clinical Research","authors":"Jayoung Kim, Junsang Oh, G. Sung, Hyeyoung Lee, J. Choi, Sangheun Lee, Minbum Kim, S. Choi","doi":"10.17966/jmi.2019.24.3.69","DOIUrl":null,"url":null,"abstract":"A \"pathogen resource\" contains information about pathogens (e.g., bacteria, fungi, viruses, and protozoa) and microbial derivatives (e.g., DNA, RNA, plasmid, clone, and cDNA). Pathogen resources are important for their potential use in healthcare research because they contain clinical and epidemiological information that is different from microbial resources. In October 2014, the \"Nagoya Protocol\" on access and benefit-sharing with the Convention on Biological Diversity was enacted to restrict the movement of transboundary pathogens and protect the natural pathogen resources of each country. On July 2017, the Korean Medical Fungal Pathogen Resource Bank (KMFRB) was established to secure, discover, and develop biological resources focused on medical fungi. KMFRB has since been operating under the National Culture Collection for Pathogens of the National Institute of Health based on the Act No. 13992. This report aims to provide general information regarding KMFRB and suggest efficient ways to utilize human fungal pathogen resources for clinical research.","PeriodicalId":36021,"journal":{"name":"Journal of Mycology and Infection","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Mycology and Infection","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17966/jmi.2019.24.3.69","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

A "pathogen resource" contains information about pathogens (e.g., bacteria, fungi, viruses, and protozoa) and microbial derivatives (e.g., DNA, RNA, plasmid, clone, and cDNA). Pathogen resources are important for their potential use in healthcare research because they contain clinical and epidemiological information that is different from microbial resources. In October 2014, the "Nagoya Protocol" on access and benefit-sharing with the Convention on Biological Diversity was enacted to restrict the movement of transboundary pathogens and protect the natural pathogen resources of each country. On July 2017, the Korean Medical Fungal Pathogen Resource Bank (KMFRB) was established to secure, discover, and develop biological resources focused on medical fungi. KMFRB has since been operating under the National Culture Collection for Pathogens of the National Institute of Health based on the Act No. 13992. This report aims to provide general information regarding KMFRB and suggest efficient ways to utilize human fungal pathogen resources for clinical research.

查看原文本刊更多论文

高效利用韩国药用真菌病原体资源库进行临床研究

“病原体资源”包含有关病原体(如细菌、真菌、病毒和原生动物)和微生物衍生物(如DNA、RNA、质粒、克隆和cDNA)的信息。病原体资源在卫生保健研究中的潜在用途是重要的，因为它们包含不同于微生物资源的临床和流行病学信息。2014年10月，通过了《生物多样性公约》关于获取和惠益分享的“名古屋议定书”，以限制跨界病原体的流动，保护各国的自然病原体资源。韩国医用真菌病原资源库(KMFRB)于2017年7月成立，旨在确保、发现和开发以医用真菌为重点的生物资源。此后，该研究所一直根据第13992号法在国家卫生研究所的国家病原体培养库下运作。本报告旨在提供有关KMFRB的一般信息，并提出有效利用人类真菌病原体资源进行临床研究的方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Mycology and Infection Medicine-Infectious Diseases

CiteScore

0.20

自引率

0.00%

发文量

期刊介绍： The Journal of mycology and infection (Acronym: JMI, Abbreviation: J Mycol Infect) aims to publish articles of exceptional interests in the field of medical mycology. The journal originally was launched in 1996 as the Korean Journal of Medical Mycology and has reformed into the current state beginning on March of 2018. The contents of the journal should elucidate important microbiological fundamentals and provide qualitative insights to respective clinical aspects. JMI underlines the submission of novel findings and studies in clinical mycology that are enriched by analyses achieved through investigative methods. The journal should be of general interests to the scientific communities at large and should provide medical societies with advanced breadth and depth of mycological expertise. In addition, the journal supplements infectious diseases in adjunct to the field of mycology to address a well-rounded understanding of infectious disorders. The Journal of mycology and infection, which is issued quarterly, in March, June, September and December each year, published in English. The scope of the Journal of mycology and infection includes invited reviews, original articles, case reports, letter to the editor, and images in mycology. The journal is compliant to peer-review/open access and all articles undergo rigorous reviewing processes by our internationally acknowledged team of editorial boards. The articles directed to publication should encompass in-depth materials that employ scholastic values of mycology and various infectious diseases. Articles responding to critical methodology and outcomes which have potential to enhance better understanding of mycology and infectious diseases are also suitable for publication.